Full Text
HPR188 Orphan Drugs – How Will the New Proposed European Union (EU) Commission Pharmaceutical Regulation Impact Therapies for Rare Diseases?

Abstract

Authors

B. Yap J. Tomassy C.S. Hinds

Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×